Lin Pan

586 total citations
30 papers, 442 citations indexed

About

Lin Pan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Lin Pan has authored 30 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 11 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Lin Pan's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), RNA Interference and Gene Delivery (3 papers) and Acute Myeloid Leukemia Research (3 papers). Lin Pan is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), RNA Interference and Gene Delivery (3 papers) and Acute Myeloid Leukemia Research (3 papers). Lin Pan collaborates with scholars based in United States, China and United Kingdom. Lin Pan's co-authors include Mourad Tighiouart, Dong M. Shin, Susan Müller, Monica Rizzo, Marina Mošunjac, Sheryl G. A. Gabram, Michael Lowe, Jared H. Linebarger, Michael A. Cohen and Fadlo R. Khuri and has published in prestigious journals such as PLoS ONE, Cancer and International Journal of Cancer.

In The Last Decade

Lin Pan

29 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Pan United States 12 194 119 117 92 91 30 442
Assia Bassarova Norway 15 206 1.1× 108 0.9× 193 1.6× 112 1.2× 97 1.1× 26 495
Neal Fischbach United States 9 200 1.0× 88 0.7× 230 2.0× 86 0.9× 84 0.9× 21 499
Alissa Minkovsky United States 6 258 1.3× 114 1.0× 123 1.1× 89 1.0× 112 1.2× 7 542
Tülay Canda Türkiye 13 128 0.7× 141 1.2× 106 0.9× 143 1.6× 49 0.5× 46 463
Qinglong Hu United States 7 213 1.1× 48 0.4× 111 0.9× 158 1.7× 44 0.5× 10 456
Evdokia Arkoumani Greece 12 189 1.0× 129 1.1× 173 1.5× 91 1.0× 122 1.3× 21 481
Miki Yamaguchi Japan 13 76 0.4× 88 0.7× 184 1.6× 53 0.6× 35 0.4× 33 436
Sandeep Reddy United States 8 159 0.8× 138 1.2× 222 1.9× 150 1.6× 93 1.0× 18 458
R Bellino Italy 9 80 0.4× 84 0.7× 98 0.8× 65 0.7× 24 0.3× 24 382

Countries citing papers authored by Lin Pan

Since Specialization
Citations

This map shows the geographic impact of Lin Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Pan more than expected).

Fields of papers citing papers by Lin Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Pan. The network helps show where Lin Pan may publish in the future.

Co-authorship network of co-authors of Lin Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Pan. A scholar is included among the top collaborators of Lin Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Pan. Lin Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Ruixue, et al.. (2025). Downregulation of FcRn promotes ferroptosis in herpes simplex virus-1-induced lung injury. Cellular and Molecular Life Sciences. 82(1). 36–36. 3 indexed citations
3.
Zhu, Honglan, Menglin Zhang, Lin Pan, et al.. (2024). Comprehensive analysis of an endoplasmic reticulum stress-related gene prediction model and immune infiltration in idiopathic pulmonary fibrosis. Frontiers in Immunology. 14. 1305025–1305025. 6 indexed citations
4.
Kamath, Nikhil, et al.. (2023). Idiopathic pulmonary fibrosis therapy development: a clinical pharmacology perspective. Therapeutic Advances in Respiratory Disease. 17. 2683760865–2683760865. 5 indexed citations
5.
Liu, Fengling, et al.. (2023). Unraveling the enigma of B cells in diffuse large B-cell lymphoma: unveiling cancer stem cell-like B cell subpopulation at single-cell resolution. Frontiers in Immunology. 14. 1310292–1310292. 3 indexed citations
6.
Zhang, Wantong, et al.. (2021). The Effect of Cardiovascular Medications on Disease-Related Outcomes in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology. 12. 771804–771804. 5 indexed citations
7.
Cheung, Dorothy, Alice Fong, Han Ting Ding, et al.. (2021). A phase 1, randomized study to evaluate safety, tolerability, and pharmacokinetics of GDC-3280, a potential novel anti-fibrotic small molecule, in healthy subjects. Pulmonary Pharmacology & Therapeutics. 69. 102051–102051. 5 indexed citations
8.
Prasse, Antje, Murali Ramaswamy, Lin Pan, et al.. (2019). A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis. Pulmonary Therapy. 5(2). 151–163. 14 indexed citations
9.
10.
Pan, Lin, et al.. (2018). Effect of pirfenidone on gastric emptying in a rat model. Pulmonary Pharmacology & Therapeutics. 51. 41–47. 4 indexed citations
11.
Pan, Lin, et al.. (2017). A Pharmacokinetic Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Volunteers. Advances in Therapy. 34(9). 2071–2082. 14 indexed citations
12.
13.
Wang, Kun, et al.. (2014). The functional BRCA1 rs799917 genetic polymorphism is associated with gastric cancer risk in a Chinese Han population. Tumor Biology. 36(1). 393–397. 16 indexed citations
14.
Arellano, Martha, Suchita Pakkala, Amelia Langston, et al.. (2012). Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia. Cancer. 118(21). 5278–5282. 34 indexed citations
15.
Rizzo, Monica, Jared H. Linebarger, Michael Lowe, et al.. (2012). Management of Papillary Breast Lesions Diagnosed on Core-Needle Biopsy: Clinical Pathologic and Radiologic Analysis of 276 Cases with Surgical Follow-Up. Journal of the American College of Surgeons. 214(3). 280–287. 75 indexed citations
16.
Xu, Jing, Susan Müller, Sreenivas Nannapaneni, et al.. (2012). Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer. European Journal of Cancer. 48(11). 1682–1691. 42 indexed citations
17.
Arellano, Martha, Elliott F. Winton, Lin Pan, et al.. (2011). High‐dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years. Cancer. 118(2). 428–433. 11 indexed citations
18.
Pan, Lin, Zhaohui Gong, Zhiwei Zhong, et al.. (2011). Lin-28 reactivation is required for let-7 repression and proliferation in human small cell lung cancer cells. Molecular and Cellular Biochemistry. 355(1-2). 257–263. 35 indexed citations
19.
Rizzo, Monica, Harvey L. Bumpers, Joel Okoli, et al.. (2010). Improving on National Quality Indicators of Breast Cancer Care in a Large Public Hospital as a Means to Decrease Disparities for African American Women. Annals of Surgical Oncology. 18(1). 34–39. 10 indexed citations
20.
Elrod, Heath A., Songqing Fan, Susan Müller, et al.. (2010). Analysis of Death Receptor 5 and Caspase-8 Expression in Primary and Metastatic Head and Neck Squamous Cell Carcinoma and Their Prognostic Impact. PLoS ONE. 5(8). e12178–e12178. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026